The latest research study “Mucosal Atomization Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global mucosal atomization devices market size reached a value of US$ 676.5 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1,045.20 Million by 2027, exhibiting a CAGR of 7.12% during 2022-2027.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/mucosal-atomization-devices-market/requestsample
Mucosal atomization devices are drug delivering devices that administer atomized drugs to treat chronic diseases such as allergic rhinitis and sinusitis. These non-invasive devices deliver drugs through the nasal mucosa or nostrils. They consist of syringes and a small-sized atomizing tip at the end of a flexible applicator, partially covered by foam, which turns the medicine into a fine mist. These devices offer superior efficiency and allow rapid absorption of the therapeutics. They are also gaining popularity as an efficient alternative to the traditional needle-based injection drug delivery method as they are safe to use, systematic, painless, and flexible. Consequently, they are used across hospitals, specialized clinics, and ambulatory surgical centers.
COVID-19Impact on Market: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Mucosal Atomization Devices Market Trends and Drivers:
The global mucosal atomization devices market is primarily driven by the increasing demand for non-invasive and effective drug delivery systems that offer quicker recovery and less painful options.
Besides this, there has been widespread adoption of mucosal atomization devices as they help in the faster delivery of medication in the bloodstream and reduce the time of the medicine to act on the concerned medical issue. Nowadays, mucosal atomization devices are commonly available in gas-propelled variants containing highly pressurized nitrogen gas and offering convenient access to large mucosal surfaces, which is favoring the market growth.
In addition, manufacturers are launching auto-disposable variants that are safe and hygienic. Furthermore, the significant growth of the healthcare industry and the implementation of various government initiatives to promote public health is anticipated to facilitate market growth in the upcoming years.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/mucosal-atomization-devices-market
Global Mucosal Atomization Devices Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Mucosal Atomization Devices Companies:
Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare), Kurve Technology Inc., Life-Assist Inc., Medica Holdings LLC, MedTree (BTME Group Ltd.) and Teleflex Incorporated.
The report has segmented the market on the basis of region, product type, technology and end user.
Breakup by Product Type:
- Nasal Atomization Devices
- Fiber-Optic Atomization Devices
- Laryngo-Tracheal Atomization Devices
- Bottle Atomizer Devices
Breakup by Technology:
- Gas Propelled
Market Breakup by End User:
- Ambulatory Surgical Centers
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800